NCT01219543: A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. |
|
|
| Terminated | 1 | 47 | RoW | AZD1480 Daily, AZD1480 BID | AstraZeneca | Solid Tumour, Advanced Solid Malignancies, Child-Pugh A to B7 Advanced Hepatocellular Carcinoma, EGFR and/or ROS Mutant NSCLC, Lung Metastasis Carcinoma, Gastric Cancer | 12/12 | 12/12 | | |
